Actress Christina Applegate, 54, is investigating the possibility that her breast implants may be connected to her ongoing pain and fatigue, following her recent revelation of a misdiagnosis of multiple sclerosis (MS) that occurred in 2021.
During the November 10 episode of MeSsy, a podcast she co-hosts with fellow actor Jamie-Lynn Sigler, Applegate, who became well-known as a teenager in the popular sitcom Married With Children, shared that she received a study suggesting that symptoms related to breast implants can mimic those of MS.
“I can’t help but think, over the last five years, ‘What if they’re leaking and causing me harm?'” she expressed, indicating her intention to consult with her doctors about this potential link.
-
As Christina Applegate reveals MS misdiagnosis, doctor warns of wrong treatment risks
-
The subject of Lyme disease is littered with misinformation. Celebrities are part of the problem, experts say
In 2008, Applegate underwent a double mastectomy and breast reconstruction after being diagnosed with an early stage of breast cancer and discovering a BRCA1 gene mutation, which increases the risk of breast and various other cancers. On her podcast, she mentioned that it is “well past time” for her to have her implants replaced.
She has also reported experiencing increased pain and mobility issues with her right shoulder, stating that it sometimes takes her at least 10 minutes to rise from bed. She expressed that these symptoms are overwhelming due to the multitude of potential underlying causes.
This inquiry into her health follows a recent clarification from doctors in October who informed her that she does not have MS. At that time, Applegate remarked that this news brought her back to “Square 1,” as her physical challenges persist, and she is currently being tested for other potential conditions such as rheumatoid arthritis, lupus, and Lyme disease.
Although the origin of Applegate’s symptoms remains unidentified, some cases have associated breast implants with certain illnesses, albeit the exact condition is not well characterized.
Understanding breast implant illness

Breast implant illness, or BII, refers to various symptoms reported by individuals with implants, including fatigue, cognitive changes, joint pain, and muscle pain. This image features a Biocell textured breast implant by Allergan. (Nicolas Amaya/CBC)
Breast implant illness, abbreviated as BII, encompasses a range of symptoms reported by some individuals with breast implants.
As of December 31, 2025, Health Canada had documented 663 reports of symptoms or conditions associated with breast implants, equating to roughly one report for every 1,025 implants sold in Canada.
Fatigue was the most commonly reported symptom, followed by changes in mood, gastrointestinal issues, and cognitive difficulties. These reports are not confirmed cases; Health Canada notes that the current data cannot ascertain whether the implants are the cause, as other factors may also be involved.
The U.S. Food and Drug Administration (FDA) specifies that BII is not recognized as a formal medical diagnosis and lacks a specific diagnostic test. Reports of symptoms such as fatigue and joint issues do not provide clarity on their frequency or whether implants are responsible.
Julie Elliott, a patient advocate, licensed practical nurse (LPN), and Canadian representative for the Breast Implant Safety Alliance (BISA), who claims to have been diagnosed with autoimmune/inflammatory syndrome induced by adjuvants (ASIA syndrome) linked to her breast implants, mentioned to CBC News that many reported symptoms can overlap with those of MS.
-
National breast implant registry much needed but long overdue, patients and doctors say
-
Alberta women with breast implant illness urge doctors to warn others of risk
“Chronic fatigue, memory changes, concentration difficulties, numbness, tingling, nerve pain, muscle weakness, hair loss, and more — these symptoms are similar to those of MS,” Elliott explained.
However, she cautioned against jumping to conclusions about the role of Applegate’s implants. “I’m not asserting that Christina Applegate’s breast implants are the cause of her symptoms,” she stated, emphasizing that it would be “premature and irresponsible” to make that assumption.
“Similar symptoms do not automatically imply the same diagnosis,” Elliott noted. “All potential causes should be thoroughly investigated instead of being dismissed.”

Christina Applegate, left, attends the 29th Screen Actors Guild Awards in Century City, California, on February 26, 2023. (Valerie Macon/AFP/Getty Images)
Dr. Stephen Nicolaidis, a plastic surgeon based in Montreal who has treated over 1,500 patients seeking implant removal, also highlighted the importance of exploring alternative causes.
He characterized BII as a “diagnosis of exclusion,” wherein patients undergo a comprehensive evaluation, and if no other causes are identified, the possibility that the implants may be contributing to the issues should be considered.
Nicolaidis reported that patients commonly describe symptoms such as fatigue, hair loss, skin rashes, respiratory issues, joint and muscle pain, sleep disturbances, and brain fog, some of which may overlap with autoimmune symptoms.
Regarding Applegate’s symptomatology, he remarked, “The symptoms she has experienced could indeed be linked to her breast implants.” Nevertheless, he pointed out that the underlying cause of BII remains unclear, and researchers have not reached conclusive insights into how implants may contribute to these symptoms.
According to Nicolaidis, there is no specific test available to diagnose BII. While imaging might reveal silicone leakage from an implant, this finding isn’t necessary for someone to report symptoms. He also clarified that BII is distinct from implant-associated lymphoma, a type of cancer associated with certain textured implants.
Concerns about rupture, removal, and next steps
A rupture or leak presents a different concern compared to BII. The FDA lists rupture and deflation among potential complications from implants and recommends that patients consult with a healthcare professional regarding any new or unusual changes in their breasts.
Similarly, Health Canada advises individuals with implants to regularly monitor for any unusual breast changes and to discuss any signs or symptoms with their healthcare provider. Decisions regarding whether to keep, replace, or remove implants should be made in consultation with a clinician, taking into account personal symptoms, potential causes, and surgical risks, according to the agency.
The agency does not recommend preventive removal of implants due to the associated surgical risks and advises individuals experiencing symptoms to communicate these concerns with a healthcare provider.
-
Struggling with pain for years, N.S. woman heads to Montreal for breast implant removal
-
Video
The costly, complex and dangerous world of removing medical devices | The Implant Files
Nicolaidis recommended that individuals with symptoms pursue a comprehensive medical assessment. If no other causes are identified, they can then discuss the role of implants with their healthcare providers and evaluate their options.
He discontinued the insertion of breast implants in 2021, believing that the associated risks often outweigh the benefits, and he now primarily focuses on removal procedures. However, he cautioned that removal does not guarantee a cure. Some patients he has treated with MS reported only slight improvements, and individuals with diagnosed autoimmune diseases may still require medical treatment following the explant surgery.
Elliott emphasized the importance of taking implant-related symptoms seriously, while recognizing that their origins are not yet fully understood. She encouraged patients to seek well-rounded, evidence-based information and to monitor their health changes closely.
“The absence of complete answers does not imply that women’s experiences should be disregarded,” she asserted.




